Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
F., Kleinman, J
PLEASE NOTE: The information provided on this page is intended for general informational purposes only
Beyond insulin optimization, the pipeline now includes 47 disclosed programs spanning prevention, disease modification, and potential cures
Always review the stability information available for the peptide being studied before selecting a diluent
In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
US$ 25.57
US$ 21.27
US$ 23.71
US$ 29.56
US$ 25.95
US$ 21.46
